Financial results - MIT & CIPRALEX TRANS SRL

Financial Summary - Mit & Cipralex Trans Srl
Unique identification code: 37587223
Registration number: J27/505/2017
Nace: 4941
Sales - Ron
107.364
Net Profit - Ron
1.596
Employee
1
The most important financial indicators for the company Mit & Cipralex Trans Srl - Unique Identification Number 37587223: sales in 2023 was 107.364 euro, registering a net profit of 1.596 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Transporturi rutiere de marfuri having the NACE code 4941.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Mit & Cipralex Trans Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 3.475 0 0 39.454 56.154 118.382 107.364
Total Income - EUR - - - 3.475 1.806 0 39.454 56.154 118.382 107.364
Total Expenses - EUR - - - 4.765 5.641 16 31.389 49.491 98.612 104.991
Gross Profit/Loss - EUR - - - -1.289 -3.835 -16 8.064 6.663 19.770 2.373
Net Profit/Loss - EUR - - - -1.332 -3.889 -16 7.721 6.153 18.819 1.596
Employees - - - 1 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -9.0%, from 118.382 euro in the year 2022, to 107.364 euro in 2023. The Net Profit decreased by -17.166 euro, from 18.819 euro in 2022, to 1.596 in the last year.

Check the financial reports for the company - Mit & Cipralex Trans Srl

Rating financiar

Financial Rating -
Mit & Cipralex Trans Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Mit & Cipralex Trans Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mit & Cipralex Trans Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Mit & Cipralex Trans Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mit & Cipralex Trans Srl - CUI 37587223

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 5.546 17 0 0 4.969 4.328 2.822
Current Assets - - - 1.410 782 742 12.368 17.282 28.074 17.060
Inventories - - - 0 0 0 0 1.269 0 271
Receivables - - - 1.120 756 742 3.461 7.210 10.729 6.781
Cash - - - 290 25 0 8.907 8.803 17.345 10.009
Shareholders Funds - - - -1.288 -5.154 -5.070 2.746 8.839 21.491 12.526
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 8.282 5.952 5.812 9.622 13.413 10.911 7.357
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4941 - 4941"
CAEN Financial Year 4941
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 17.060 euro in 2023 which includes Inventories of 271 euro, Receivables of 6.781 euro and cash availability of 10.009 euro.
The company's Equity was valued at 12.526 euro, while total Liabilities amounted to 7.357 euro. Equity decreased by -8.900 euro, from 21.491 euro in 2022, to 12.526 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Mit & Cipralex Trans Srl

Comments - Mit & Cipralex Trans Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.